Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.83 is 929% below its 5-year average of 0.10, near the low end of its 5-year range (-0.83–0.73).
5524.84% below its 12-month average of 0.02.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.77.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:37:45.421Z. Historical observations retain their original dates. Historical series through 2026-05-07.
EARNINGS PER SHARE (EPS)
-0.83
EARNINGS PER SHARE (EPS) AVG TTM
0.02
EARNINGS PER SHARE (EPS) AVG 3Y
0.22
EARNINGS PER SHARE (EPS) AVG 5Y
0.10
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-5524.84%
CURRENT VS 3Y AVG
-477.02%
CURRENT VS 5Y AVG
-929.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Organogenesis Holdings Inc.
Market Cap
$169.21M
Earnings Per Share (EPS)
-0.83
TTM Avg
0.02
3Y Avg
0.22
5Y Avg
0.10
Market Cap
$168.66M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$170.85M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
Market Cap
$170.91M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.59
3Y Avg
-0.77
5Y Avg
-0.88
Market Cap
$166.66M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$165.17M
Earnings Per Share (EPS)
0.23
TTM Avg
-0.41
3Y Avg
-0.62
5Y Avg
-0.44
Market Cap
$164.91M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
Market Cap
$174.81M
Earnings Per Share (EPS)
-0.46
TTM Avg
-0.40
3Y Avg
-0.54
5Y Avg
-0.73
Market Cap
$175.95M
Earnings Per Share (EPS)
-23.45
TTM Avg
-38.87
3Y Avg
-195.80
5Y Avg
-1526.80
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $169.21M | -0.83 | 0.02 | 0.22 | 0.10 |
| MediWound Ltd. (MDWD)vs › | $168.66M | -1.60 | -2.56 | -2.45 | -2.61 |
| Precision BioSciences, Inc. (DTIL)vs › | $170.85M | -2.80 | -1.25 | -14.14 | -22.50 |
| Journey Medical Corporation (DERM)vs › | $170.91M | -0.23 | -0.59 | -0.77 | -0.88 |
| Cue Biopharma, Inc. (CUE)vs › | $166.66M | -27.00 | -15.00 | -27.00 | -32.85 |
| OptimizeRx Corp. (OPRX)vs › | $165.17M | 0.23 | -0.41 | -0.62 | -0.44 |
| Nkarta, Inc. (NKTX)vs › | $164.91M | -1.57 | -1.50 | -2.00 | -2.13 |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.81M | -0.46 | -0.40 | -0.54 | -0.73 |
| Yarrow Bioscience Inc (YARW)vs › | $175.95M | -23.45 | -38.87 | -195.80 | -1526.80 |
| Quanterix Corporation (QTRX)vs › | $162.44M | -2.63 | -1.75 | -1.74 | -1.61 |
Trailing EPS (TTM)
$-0.83
Forward EPS (Est.)
$-1.38
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | -0.01 |
| 2023-12-31 | 0.04 |
| 2022-12-31 | 0.12 |
| 2021-12-31 | 0.73 |
| 2020-12-31 | 0.16 |
| 2019-12-31 | -0.44 |
| 2018-12-31 | -0.94 |
| 2017-12-31 | -0.03 |
| 2016-12-31 | -0.02 |
